A new perspective on calcium channel blockers in vasospastic angina.
作者信息
Kim Hack-Lyoung
机构信息
Division of Cardiology, Department of Internal Medicine, Seoul Metropolitan Government- Seoul National University Boramae Medical Center, Seoul, Korea.
出版信息
Korean J Intern Med. 2021 Jan;36(1):63-64. doi: 10.3904/kjim.2020.628. Epub 2021 Jan 1.
Abstract
摘要
相似文献
1
A new perspective on calcium channel blockers in vasospastic angina.
Korean J Intern Med. 2021 Jan;36(1):63-64. doi: 10.3904/kjim.2020.628. Epub 2021 Jan 1.
2
Vasospastic angina and Ca channel blockers.
Curr Hypertens Rev. 2013 Aug;9(3):219-23. doi: 10.2174/1573402110666140131161338.
3
Clinical efficacy of benidipine for vasospastic angina pectoris.
Arzneimittelforschung. 2007;57(1):20-5. doi: 10.1055/s-0031-1296581.
4
Prognostic factors for the long-term survival in patients with vasospastic angina--analysis of effects of patients' characteristics and therapeutic drugs.
J Cardiol. 2009 Aug;54(1):10-20. doi: 10.1016/j.jjcc.2009.02.013. Epub 2009 Apr 1.
5
Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test.
Arzneimittelforschung. 2007;57(9):573-81. doi: 10.1055/s-0031-1296652.
6
Pharmacotherapy of Vasospastic Angina.
J Cardiovasc Pharmacol Ther. 2016 Sep;21(5):439-51. doi: 10.1177/1074248416640161. Epub 2016 Apr 13.
7
Coronary artery vasoconstriction and its treatment with calcium channel blockers.
Ala J Med Sci. 1985 Jul;22(3):271-4.
8
[Calcium channel blockers in ischemic cardiopathies].
Therapie. 1989 May-Jun;44(3):155-9.
9
Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease.
Am J Cardiol. 2005 Jan 1;95(1):84-7. doi: 10.1016/j.amjcard.2004.08.064.
10
Coronary vasospasm at the site of myocardial bridge--report of two cases.
Angiology. 1998 Aug;49(8):659-63. doi: 10.1177/000331979804900812.
引用本文的文献
1
Drug-Induced Myocardial Infarction: A Review of Pharmacological Triggers and Pathophysiological Mechanisms.
J Cardiovasc Dev Dis. 2024 Dec 18;11(12):406. doi: 10.3390/jcdd11120406.
2
Acute coronary syndrome due to coronary vasospasm: a case report.
Future Cardiol. 2024;20(11-12):613-618. doi: 10.1080/14796678.2024.2392995. Epub 2024 Sep 4.
3
Ischaemia with no obstructive coronary arteries: a review with focus on the Asian population.
Singapore Med J. 2024 Jul 1;65(7):380-388. doi: 10.4103/singaporemedj.SMJ-2023-116. Epub 2024 Jul 8.
4
Vasospastic angina: a review on diagnostic approach and management.
Ther Adv Cardiovasc Dis. 2024 Jan-Dec;18:17539447241230400. doi: 10.1177/17539447241230400.
5
Diltiazem is a useful and effective medication for reversal of coronary artery spasm-induced complete atrioventricular block: A case report.
Front Cardiovasc Med. 2023 Apr 3;10:1134658. doi: 10.3389/fcvm.2023.1134658. eCollection 2023.
6
Comparison of various calcium antagonist on vasospastic angina: a systematic review.
Open Heart. 2023 Jan;10(1). doi: 10.1136/openhrt-2022-002179.
本文引用的文献
1
Comparison of calcium-channel blockers for long-term clinical outcomes in patients with vasospastic angina.
Korean J Intern Med. 2021 Jan;36(1):124-134. doi: 10.3904/kjim.2019.308. Epub 2020 Feb 24.
2
Prognostic effects of calcium channel blockers in patients with vasospastic angina--a meta-analysis.
Circ J. 2010 Sep;74(9):1943-50. doi: 10.1253/circj.cj-10-0292. Epub 2010 Jul 21.
3
Prognostic effects of benidipine in patients with vasospastic angina: comparison with diltiazem and amlodipine.
J Cardiovasc Pharmacol. 2008 Mar;51(3):253-7. doi: 10.1097/FJC.0b013e3181624b05.
4
Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test.
Arzneimittelforschung. 2007;57(9):573-81. doi: 10.1055/s-0031-1296652.
5
Calcium-channel modulators for cardiovascular disease.
Expert Opin Emerg Drugs. 2006 Mar;11(1):49-73. doi: 10.1517/14728214.11.1.49.
6
Coronary spasm: clinical features and pathogenesis.
Intern Med. 1997 Nov;36(11):760-5. doi: 10.2169/internalmedicine.36.760.
7
Randomized placebo-controlled trial of amlodipine in vasospastic angina. Amlodipine Study 160 Group.
J Am Coll Cardiol. 1993 May;21(6):1365-70. doi: 10.1016/0735-1097(93)90310-w.
8
Efficacy of diltiazem for control of symptoms of coronary arterial spasm.
Am J Cardiol. 1980 Dec 1;46(6):1027-32. doi: 10.1016/0002-9149(80)90362-8.
9
Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan.
Circulation. 1981 Apr;63(4):844-8. doi: 10.1161/01.cir.63.4.844.
10
Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm.
N Engl J Med. 1992 May 28;326(22):1451-5. doi: 10.1056/NEJM199205283262202.
Zotero 插件